Stevens-Johnson syndrome secondary to erythromycin.
Sullivan
S
S
Department of Medicine, University of Mississippi Medical Center, Jackson 39216, USA.
Harger
B
B
Cleary
J D
JD
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004917:Erythromycin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D010033:Otitis Media / Q000150:complications / Q000188:drug therapy; D012867:Skin / Q000473:pathology; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced* / Q000473:pathology
D000900:Anti-Bacterial Agents; D004917:Erythromycin